Latest filing published 04 Apr 2022 for AMEDISYS INC, €3,158.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
David L. Kemmerly: trading record in brief
David L. Kemmerly discloses dealings in Amedisys Inc to SEC (Form 4). The record holds 83 filings, for trades running from 4 June 2016 to 29 March 2022.
On the market, this insider has only sold: 33 sales, €11.3M in total. Outside the open market, there are 26 share grants and 24 option exercises. 2022 to date brings no purchases and 3 sales.
The latest filing, published on 4 April 2022, reports an open-market sale of €325k in Amedisys Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to David L. Kemmerly
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20 shares@ US$175.16100.0% of flowCommon StockSEC:0000896262-22-000022:0
- 1,309 shares0Common StockSEC:0000896262-22-000014:0
2 of 2 declarations
